LabCorp to Present on Companion Diagnostics at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference (July 23-24, 2007, San Diego, CA)
Monrovia, CA, June 23, 2007 --(PR.com)-- Dr. Steven M. Anderson, National Director of Research and Development at Laboratory Corporation of America will present on Development of Companion Diagnostics: Role of Clinical Reference Laboratories at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA.
Companion diagnostics will be of increasing importance in healthcare through the linkage of therapy decisions with information and guidance provided by specific diagnostic test results. Companion diagnostic assays may have a variety of clinical uses, including the assessment of the potential efficacy or toxicity of a given therapy and/or drug. Clinical reference laboratories can play a significant role in the development of companion diagnostic tests through a variety of means including: assay method and platform design, determination of analytical performance characteristics of the assay, and performance of clinical trial studies to address the clinical validity of a biomarker(s). Clinical laboratories are also able to provide a bridge between companies involved in therapeutic development and diagnostic companies that develop assays and assay platforms. This presentation will discuss these and other factors that are important for the successful development and introduction of companion diagnostics.
GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference provides comprehensive coverage of a wide range of topics including Biomarker Application in Oncology Clinical Development, Drug Discovery, Development and Diagnostics of Biomarkers, Tools for Improving Measurement, Safety and Validation of Biomarkers, and Upcoming Technology and Trends.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://www.gtcbio.com/conference/conferenceDetails.aspx?id=101
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Companion diagnostics will be of increasing importance in healthcare through the linkage of therapy decisions with information and guidance provided by specific diagnostic test results. Companion diagnostic assays may have a variety of clinical uses, including the assessment of the potential efficacy or toxicity of a given therapy and/or drug. Clinical reference laboratories can play a significant role in the development of companion diagnostic tests through a variety of means including: assay method and platform design, determination of analytical performance characteristics of the assay, and performance of clinical trial studies to address the clinical validity of a biomarker(s). Clinical laboratories are also able to provide a bridge between companies involved in therapeutic development and diagnostic companies that develop assays and assay platforms. This presentation will discuss these and other factors that are important for the successful development and introduction of companion diagnostics.
GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference provides comprehensive coverage of a wide range of topics including Biomarker Application in Oncology Clinical Development, Drug Discovery, Development and Diagnostics of Biomarkers, Tools for Improving Measurement, Safety and Validation of Biomarkers, and Upcoming Technology and Trends.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://www.gtcbio.com/conference/conferenceDetails.aspx?id=101
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Contact
GTCbio
Rania Hafez
626-256-6405
www.gtcbio.com
Rania Hafez
626-256-6405
www.gtcbio.com
Contact
Categories